Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Aging causes hair to gray and thin, with the timing of graying varying by race, and factors like oxidative stress and genetics can lead to hair loss.

Hair transplantation is a treatment for hair loss mainly caused by genetics, with various techniques and potential complications, and results visible after 8-12 months.

Cutting and implanting hair follicles can create finer, more natural-looking hairlines, with about half of the implanted hairs growing back.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.

New treatments for hair loss are being developed using molecular biology.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Kali carbonicum helped regrow beard hair and reduce anxiety in a man with alopecia areata barbae.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Scientists found cells in hair that are key for growth and color.

Finasteride may help some women with hair loss, but better options exist.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

The OVOL1-OVOL2 axis is important for hair follicle differentiation and can help diagnose certain hair-related tumors.

Hair loss needs more research for better treatments.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

S100A4 and S100A6 proteins may activate stem cells for hair follicle regeneration and could be potential targets for hair loss treatments.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Damaging mitochondrial DNA in mice speeds up aging due to increased reactive oxygen species, not through the p53/p21 pathway.

Changing Wnt signaling can lead to more or less hair growth and might help treat hair loss and skin conditions.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Immune cells affect hair growth and could lead to new hair loss treatments.